Evaluating outcomes of chest wall reconstruction procedures
Reconstructions of Chest Wall Defects: a Retrospective Study
This study looks at how well patients with chest wall defects do after surgery and what factors help them recover better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06774755 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the outcomes of patients who have undergone thoracic and sternal reconstruction due to complex chest wall defects. It focuses on the preoperative stabilization of patients with comorbidities and the assessment of spirometric characteristics to ensure they can tolerate surgical interventions. By retrospectively reviewing past cases at the IRCCS AOU di Bologna, the study seeks to identify the most effective diagnostic and therapeutic approaches, ultimately aiming to improve multidisciplinary management and develop standardized protocols for treatment.
Who should consider this trial
Good fit: Ideal candidates include patients requiring sternal or thoracic reconstruction who have provided informed consent.
Not a fit: Patients who do not require surgical intervention for chest wall defects may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and quality of life for patients with complex chest wall defects.
How similar studies have performed: While there is a lack of universally accepted guidelines for chest wall reconstruction, this study aims to build on existing knowledge, suggesting that similar approaches may have been explored but not standardized.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients undergoing sternal or thoracic reconstruction in collaboration or not with the Reconstructive Plastic Surgery Unit * Obtaining informed consent Exclusion Criteria: \-
Where this trial is running
Bologna
- IRCCS AOU di Bologna Policlinico di Sant'Orsola — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Marco Pignatti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Marco Pignatti, MD
- Email: marco.pignatti@unibo.it
- Phone: +390512143614
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.